1-(3-ChloroMethyl-piperidin-1-yl)-ethanone
- $92 - $911
- Product name: 1-(3-ChloroMethyl-piperidin-1-yl)-ethanone
- CAS: 1082844-32-3
- MF: C8H14ClNO
- MW: 175.66
- EINECS:
- MDL Number:MFCD11612379
- Synonyms:1-(3-ChloroMethyl-piperidin-1-yl)-ethanone;1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one;Ethanone, 1-[3-(chloromethyl)-1-piperidinyl]-
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 100mg
- 500mg
- 1g
- 2.500g
- ManufacturerCrysdot
- Product numberCD11355266
- Product description1-(3-(Chloromethyl)piperidin-1-yl)ethanone 97%
- Packaging1g
- Price$613
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number134131
- Product description1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+
- Packaging100mg
- Price$92
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number134131
- Product description1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+
- Packaging500mg
- Price$256
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number134131
- Product description1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+
- Packaging2.500g
- Price$911
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11355266 | 1-(3-(Chloromethyl)piperidin-1-yl)ethanone 97% | 1g | $613 | 2021-12-16 | Buy |
Matrix Scientific | 134131 | 1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+ | 100mg | $92 | 2021-12-16 | Buy |
Matrix Scientific | 134131 | 1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+ | 500mg | $256 | 2021-12-16 | Buy |
Matrix Scientific | 134131 | 1-[3-(Chloromethyl)piperidin-1-yl]ethan-1-one 95%+ | 2.500g | $911 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|